(Q31531733)

English

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

circulatory system

1 reference

based on heuristic

inferred from title

Thomas Lüscher

1

object named as

T F Lüscher

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

author name string

M Barton

2

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

102

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

2434-2440

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.95.5.2664

Identifiers

10.1161/01.CIR.102.19.2434

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31531733&oldid=2041813145"